Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis

Blood

Volumn 113, Issue 23, 2009, Pages 6015-6022

  Kisucka, Janka ^a,b   Chauhan, Anil K ^a,c   Zhao, Bing Qiao ^a   Patten, Ian S ^a   Yesilaltay, Ayce ^b   Krieger, Monty ^b   Wagner, Denisa D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PADGEM PROTEIN; APOLIPOPROTEIN E;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL BEHAVIOR; STROKE; ANIMAL; BLOOD; BRAIN INFARCTION; GENETICS; METABOLISM; PATHOLOGY; SOLUBILITY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD-BRAIN BARRIER; CEREBRAL INFARCTION; FEMALE; MALE; MICE; P-SELECTIN; SOLUBILITY;

EID: 67649523011     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-186650     Document Type: Article

References (56)

1. Wagner DD, Frenette PS. The vessel wall and its interactions. Blood. 2008;111:5271-5281.
2. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99. (Pubitemid 19170099)
3. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541-554. (Pubitemid 23244619)
4. Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem. 1990;265:21381-21385.
5. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100:97-103.
6. Disdier M, Morrissey JH, Fugate RD, Bainton DF, McEver RP. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell. 1992;3:309-321. (Pubitemid 23095967)
7. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003;23:2131-2137.
8. Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD. Defects in hemostasis in P-selectin-deficient mice. Blood. 1996;87:1238-1242.
9. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 2000;101:2290-2295.
10. Ishiwata N, Takio K, Katayama M, et al. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem. 1994;269:23708-23715. (Pubitemid 24293578)
11. Sampietro T, Tuoni M, Ferdeghini M, et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997;96:1381-1385. (Pubitemid 27375325)
12. Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens. 1995;13:1674-1678. (Pubitemid 26015796)
13. Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke. 1997;28:2214-2218. (Pubitemid 27497925)
14. Blann AD, Lip GY, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemostasis. 1997;77:1077-1080. (Pubitemid 27311972)
15. Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin-Dusting J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res. 2006;98:149-156. (Pubitemid 43970215)
16. Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J. 1997;133:387-392. (Pubitemid 27188456)
17. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491-495.
18. Hartwell DW, Mayadas TN, Berger G, et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol. 1998;143:1129-1141. (Pubitemid 28547409)
19. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A. 2000;97:13835-13840.
20. Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med. 2007;204:1999-2008. (Pubitemid 47236333)
21. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the Factor V Leiden mutation. Blood. 2000;96:4222-4226.
22. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997;94:12610-12615. (Pubitemid 27492576)
23. Connolly ES Jr, Winfree CJ, Prestigiacomo CJ, et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res. 1997;81:304-310.
24. Nadar SK, Lip GY, Blann AD. Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke: the West Birmingham Stroke Project. Thromb Haemostasis. 2004;92:1342-1348.
25. Cambien B, Wagner DD. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med. 2004;10:179-186. (Pubitemid 38410976)
26. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91:8767-8771.
27. Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med. 2003;9:1020-1025. (Pubitemid 37021781)
28. del Conde I, Nabi F, Tonda R, Thiagarajan P, López JA, Kleiman NS. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol. 2005;5:1065-1070. (Pubitemid 40627856)
29. + T lymphocytes and regulates their production of proinflammatory cytokines. Eur J Immunol. 1992;22:1789-1793.
30. Evangelista V, Manarini S, Sideri R, et al. Platelet/Polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation- dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999;93:876-885. (Pubitemid 29067852)
31. Wang HB, Wang JT, Zhang L, et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol. 2007;8:882-892. (Pubitemid 47099040)
32. Woollard KJ, Suhartoyo A, Harris EE, et al. Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res. 2008;103:1128-1138.
33. Woollard KJ. Soluble bio-markers in vascular disease: much more than gauges of disease? Clin Exp Pharmacol Physiol. 2005;32:233-240.
34. Kadish JL, Butterfield CE, Folkman J. The effect of fibrin on cultured vascular endothelial cells. Tissue Cell. 1979;11:99-108. (Pubitemid 9136073)
35. Bach TL, Barsigian C, Yaen CH, Martinez J. Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem. 1998;273:30719-30728. (Pubitemid 28545554)
36. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation. 2003;10:463-470. (Pubitemid 39004272)
37. Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;175:612-617. (Pubitemid 46438946)
38. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnea: data from randomized controlled trials. Thorax. 2004;59:777-782.
39. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041. (Pubitemid 41609096)
40. Kamath AF, Chauhan AK, Kisucka J, et al. Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood. 2006;107:591-593. (Pubitemid 43090794)
41. Methia N, Andre P, Hafezi-Moghadam A, Economopoulos M, Thomas KL, Wagner DD. ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med. 2001;7:810-815. (Pubitemid 34175304)
42. Hafezi-Moghadam A, Thomas KL, Wagner DD. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am J Physiol. 2007;292:1256-1262. (Pubitemid 46631730)
43. Anello G, Gueant-Rodriguez RM, Bosco P, et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. NeuroReport. 2004;15:859-861. (Pubitemid 38453474)
44. Zhang R, Chopp M, Zhang Z, Jiang N, Powers C. The expression of P- and E-selectins in three models of middle cerebral artery occlusion. Brain Res. 1998;785:207-214. (Pubitemid 28179383)
45. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischemic stroke. Thromb Res. 2006;118:67-74.
46. Mocco J, Choudhri T, Huang J, et al. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res. 2002;91:907-914. (Pubitemid 35373590)
47. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115:2323-2330. (Pubitemid 46685900)
48. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques: coexpression with intercellular adhesion molecule-1. Am J Pathol. 1994;144:952-961.
49. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237-1244. (Pubitemid 29270037)
50. Chironi G, Dosquet C, Del-Pino M, et al. Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men. Am J Hypertens. 2006;19:1025-1031. (Pubitemid 44488665)
51. Libby P. Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation. Circ Res. 2007;100:299-301. (Pubitemid 46272401)
52. Eitzman DT, Westrick RJ, Bi X, et al. Homozygosity for Factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation. 2005;111:1822-1825.
53. Westrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation. 2001;103:3044-3046. (Pubitemid 32587848)
54. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood. 2003;101:2661-2666.
55. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61-67. (Pubitemid 36098261)
56. Davi G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation. 1998;97:953-957. (Pubitemid 28125466)